Biocon is among the companies that gave a good performance in 2016 and the stock surged 80 percent this year. Speaking to CNBC-TV18, Kiran Mazumdar Shaw, CMD of the company, said the company has gained traction in many emerging markets with its biosimilars.
first published: Dec 22, 2016 12:02 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

